Glycemic variability: A strong independent predictor of mortality in critically ill patients.
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: To determine the effect of glycemic variability, assessed by the standard deviation of each patient's mean glucose level, on mortality in a population of critically ill adult patients. DESIGN: Retrospective review of a large cohort of prospectively evaluated patients. SETTING: Fourteen-bed medical surgical adult intensive care unit of a university affiliated community hospital. PATIENTS: Three thousand two hundred fifty-two patients consecutively admitted between October 1999 and October 2007 with at least three venous glucose samples. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: The mean (sd) Acute Physiology and Chronic Health Evaluation II score of the 3252 patients was 20.0 (8.9) and their mortality was 24.4%, ranging from 18.1% among patients with mean glucose level 70 mg/dL to 99 mg/dL to 35.9% among patients with mean glucose level 180+ mg/dL. The relationship between glycemic variability and mortality was strongest in the euglycemic range. For the 410 patients with mean glucose level 70 mg/dL to 99 mg/dL, mortality ranged from 5.9% in the first quartile of glycemic variability to 30.1% in the fourth; for the 1031 patients with mean glucose level 100 mg/dL to 119 mg/dL the corresponding range was 9.7% to 31.0%. Mortality among patients in the entire cohort with the lowest quartile of glycemic variability was 12.1%, increasing to 19.9%, 27.7%, and 37.8% in the second, third, and fourth quartiles. Intensive care unit length of stay was shorter among patients in the first quartile compared with those in the other three (p < .001). CONCLUSIONS: This study demonstrates that increasing glycemic variability conferred a strong independent risk of mortality in this heterogeneous population of critically ill patients. Previously published interventional studies of glycemic control may be reinterpreted using the metric of glycemic variability. Measures to ensure a low degree of glycemic variability may improve outcomes in intensive care unit's implementing glycemic control. Finally, ongoing and future investigations should consider including this new metric in their study design.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hyperglycemia (> 180 mg/dL), hypoglycemia and increased glycemic variability are associated with increased mortality in critically ill patients [509–511].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [510]
Citations
Cites
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 1×
“The first Leuven study, performed in a surgical ICU, is widely considered to be more “positive” in support of intensive glycemic management than is the second, completed in a medical ICU (10, 11, 30).”
Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J.-P., & Colette, C. (2006) · JAMA · doi:10.1001/jama.295.14.1681 · Cited by 2,444
Capes, S. E., Hunt, D., Malmberg, K., & Gerstein, H. C. (2000) · The Lancet · doi:10.1016/s0140-6736(99)08415-9 · Cited by 2,187 · cited 1×
“Diagnostic categories include, in part, medical and surgical neurologic illness (2, 3), acute coronary syndromes (4, 5), cardiovascular surgery (6), and a variety of different intensive care unit (ICU) populations (7–9).”
BackgroundCapes, S. E., Hunt, D., Malmberg, K., Pathak, P., & Gerstein, H. C. (2001) · Stroke · doi:10.1161/hs1001.096194 · Cited by 1,824
Effect of an Intensive Glucose Management Protocol on the Mortality of Critically Ill Adult Patients
Krinsley, J. S. (2004) · Mayo Clinic Proceedings · doi:10.4065/79.8.992 · Cited by 1,223
Self-citationKrinsley, J. S. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.12.1471 · Cited by 1,165
Self-citationVariability of Blood Glucose Concentration and Short-term Mortality in Critically Ill Patients
Egi, M., Bellomo, R., Stachowski, E., French, C. J., & Hart, G. (2006) · Anesthesiology · doi:10.1097/00000542-200608000-00006 · Cited by 854
Quagliaro, L., Piconi, L., Assaloni, R., Martinelli, L., Motz, E., & Ceriello, A. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2795 · Cited by 769
Lazar, H. L., Chipkin, S. R., Fitzgerald, C. A., Bao, Y., Cabral, H., & Apstein, C. S. (2004) · Circulation · doi:10.1161/01.cir.0000121747.71054.79 · Cited by 717
Research works printed but not linked: 2
- Brunkhorst, 2005, Infection, 33, 19
- Van den Berghe, 2004, J Clin Invest, 114, 1187, 10.1172/jci23506 · doi:10.1172/jci23506 · Paper page
Cited by
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Alhazzani, W., Møller, M. H., Arabi, Y. M., Loeb, M., Gong, M. N., Fan, E., Oczkowski, S., Levy, M. M., Derde, L., Dzierba, A., et al. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004363 · Cited by 1,565
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.gl · Cited by 629
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.glsuppl · Cited by 559
Handelsman, Y., Mechanick, J. I., Blonde, L., Grunberger, G., Bloomgarden, Z. T., Bray, G. A., Dagogo-Jack, S., Davidson, J. A., Einhorn, D., Ganda, O., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.s2.1 · Cited by 513
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Glucose variability is associated with intensive care unit mortality*
Hermanides, J., Vriesendorp, T. M., Bosman, R. J., Zandstra, D. F., Hoekstra, J. B., & DeVries, J. H. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181cc4be9 · Cited by 437
Glycemic Variability: How Do We Measure It and Why Is It Important?
Suh, S., & Kim, J. H. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.4.273 · Cited by 439
Glucose Variability; Does It Matter?
Siegelaar, S. E., Holleman, F., Hoekstra, J. B. L., & DeVries, J. H. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0021 · Cited by 409
Krinsley, J. S., Egi, M., Kiss, A., Devendra, A. N., Schuetz, P., Maurer, P. M., Schultz, M. J., van Hooijdonk, R. T., Kiyoshi, M., Mackenzie, I. M., et al. (2013) · Critical Care · doi:10.1186/cc12547 · Cited by 369
Self-citationThe Impact of Early Hypoglycemia and Blood Glucose Variability on Outcome in Critical Illness
Bagshaw, S. M., Bellomo, R., Jacka, M. J., Egi, M., Hart, G. K., George, C., & the ANZICS CORE Management Committee (2009) · Critical Care · doi:10.1186/cc7921 · Cited by 285
“In a retrospective analysis of a large cohort of consecutively admitted critically ill patients, Krinsley [24] found the association between BG variability and mortality was strongest for BG in the normal range.”
BackgroundInfluentialKim, M. K., Han, K., Park, Y.-M., Kwon, H.-S., Kang, G., Yoon, K.-H., & Lee, S.-H. (2018) · Circulation · doi:10.1161/circulationaha.118.034978 · Cited by 267
Su, G., Mi, S., Tao, H., Li, Z., Yang, H., Zheng, H., Zhou, Y., & Ma, C. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-19 · Cited by 257
Intensive Insulin Therapy in Critically Ill Patients: NICE-SUGAR or Leuven Blood Glucose Target?
Van den Berghe, G., Schetz, M., Vlasselaers, D., Hermans, G., Wilmer, A., Bouillon, R., & Mesotten, D. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0663 · Cited by 235
‘Glycaemic variability’: a new therapeutic challenge in diabetes and the critical care setting
Ceriello, A., & Ihnat, M. A. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.02967.x · Cited by 233
Mendez, C. E., Mok, K.-T., Ata, A., Tanenberg, R. J., Calles-Escandon, J., & Umpierrez, G. E. (2013) · Diabetes Care · doi:10.2337/dc12-2430 · Cited by 209
Smith-Palmer, J., Brändle, M., Trevisan, R., Orsini Federici, M., Liabat, S., & Valentine, W. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.06.007 · Cited by 212
Kavanagh, B. P., & McCowen, K. C. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp1001115 · Cited by 205
Meyfroidt, G., Keenan, D. M., Wang, X., Wouters, P. J., Veldhuis, J. D., & Van den Berghe, G. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181cf710e · Cited by 196
Glycemic Variability and Mortality in Critically 111 Patients: The Impact of Diabetes
Krinsley, J. S. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300609 · Cited by 192
Self-citationPostprandial Hyperglycemia and Glycemic Variability
Standl, E., Schnell, O., & Ceriello, A. (2011) · Diabetes Care · doi:10.2337/dc11-s206 · Cited by 183
“Recently, Krinsley (33) reported a strong and independent relationship between glycemic variability and mortality in a large cohort of patients with a variety of medical, surgical, and trauma diagnoses in an intensive care unit.”
BackgroundMild hypoglycemia is independently associated with increased mortality in the critically ill
Krinsley, J. S., Schultz, M. J., Spronk, P. E., Harmsen, R. E., van Braam Houckgeest, F., van der Sluijs, J. P., Mélot, C., & Preiser, J. C. (2011) · Critical Care · doi:10.1186/cc10322 · Cited by 178
Self-citationGlucose variability: An emerging target for the treatment of diabetes mellitus
Frontoni, S., Di Bartolo, P., Avogaro, A., Bosi, E., Paolisso, G., & Ceriello, A. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.09.007 · Cited by 174
Su, G., Mi, S.-H., Tao, H., Li, Z., Yang, H.-X., Zheng, H., Zhou, Y., & Tian, L. (2013) · Diabetes Care · doi:10.2337/dc12-0925 · Cited by 175
Duncan, A. E., Abd-Elsayed, A., Maheshwari, A., Xu, M., Soltesz, E., & Koch, C. G. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181d3d4b4 · Cited by 171
Scientific Principles and Clinical Implications of Perioperative Glucose Regulation and Control
Akhtar, S., Barash, P. G., & Inzucchi, S. E. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181c6be63 · Cited by 176
Krinsley, J. S., & Preiser, J.-C. (2015) · Critical Care · doi:10.1186/s13054-015-0908-7 · Cited by 174
“A robust literature has demonstrated that hyperglycemia, hypoglycemia and increased glucose variability are independently associated with mortality in diverse cohorts of critically ill patients [12-22] and that diabetic status modulates these relationships [23-25].”
BackgroundSelf-citationGlucose control in the intensive care unit
Fahy, B. G., Sheehy, A. M., & Coursin, D. B. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181a19ceb · Cited by 170
Glucose variability measures and their effect on mortality: a systematic review
Eslami, S., Taherzadeh, Z., Schultz, M. J., & Abu–Hanna, A. (2011) · Intensive Care Medicine · doi:10.1007/s00134-010-2129-5 · Cited by 162
Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial
Thabit, H., Hartnell, S., Allen, J. M., Lake, A., Wilinska, M. E., Ruan, Y., Evans, M. L., Coll, A. P., & Hovorka, R. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30280-7 · Cited by 137
Association between intensive care unit-acquired dysglycemia and in-hospital mortality.
Badawi, O., Waite, M. D., Fuhrman, S. A., & Zuckerman, I. H. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182656ae5 · Cited by 142
Lu, Z., Tao, G., Sun, X., Zhang, Y., Jiang, M., Liu, Y., Ling, M., Zhang, J., Xiao, W., Hua, T., et al. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.857368 · Cited by 147
Chase, J. G., Compte, A. J. L., Suhaimi, F. M., Shaw, G. M., Lynn, A. M., Lin, J., Pretty, C. G., Razak, N. N. A., Parente, J. D., Hann, C. E., et al. (2010) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2010.11.006 · Cited by 141
Sechterberger, M. K., Bosman, R. J., Oudemans-van Straaten, H. M., Siegelaar, S. E., Hermanides, J., Hoekstra, J. B., & De Vries, J. H. (2013) · Critical Care · doi:10.1186/cc12572 · Cited by 128
Desai, S. P., Henry, L. L., Holmes, S. D., Hunt, S., Martín, C., Hebsur, S., & Ad, N. (2011) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2011.10.070 · Cited by 137
Clinical Interpretation of Indices of Quality of Glycemic Control and Glycemic Variability
Rodbard, D. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.07.2310 · Cited by 127
STAR Development and Protocol Comparison
Fisk, L., Compte, A. J. L., Shaw, G. M., Penning, S., Desaive, T., & Chase, J. G. (2012) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2012.2214384 · Cited by 134
S3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge
Deutsche Sepsis Gesellschaft e., V., Brunkhorst, F. M., Weigand, M. A., Pletz, M. W., Gastmeier, P., Lemmen, S., Meier‐Hellmann, A., Ragaller, M., Weyland, A., Marx, G., et al. (2020) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-020-00685-0 · Cited by 148
International recommendations for glucose control in adult non diabetic critically ill patients
Ichai, C., Preiser, J.-C., (SFAR), F. T. S. F. D.-R., & Société de Réanimation de langue Française (SRLF) and the Experts group (2010) · Critical Care · doi:10.1186/cc9258 · Cited by 127
“Several studies have confirmed that acute glucose variations are an independent predictive factor of mortality [13,33-35].”
BackgroundJuarez, D. T., Sentell, T., Tokumaru, S., Goo, R., Davis, J. W., & Mau, M. M. (2012) · Preventing Chronic Disease · doi:10.5888/pcd9.120065 · Cited by 122
Increased blood glucose variability during therapeutic hypothermia and outcome after cardiac arrest*
Villoz, N., Devigili, A., Delodder, F., Cianferoni, S., Feihl, F., Rossetti, A. O., Eggimann, P., Vincent, J., Taccone, F. S., & Oddo, M. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31822572c9 · Cited by 125
Validation of a model-based virtual trials method for tight glycemic control in intensive care
Chase, J. G., Suhaimi, F. M., Penning, S., Preiser, J., Compte, A. J. L., Lin, J., Pretty, C. G., Shaw, G. M., Moorhead, K. T., & Desaive, T. (2010) · BioMedical Engineering OnLine · doi:10.1186/1475-925x-9-84 · Cited by 133
Leelarathna, L., English, S. W., Thabit, H., Caldwell, K., Allen, J. M., Kumareswaran, K., Wilinska, M. E., Nodale, M., Mangat, J., Evans, M. L., et al. (2013) · Critical Care · doi:10.1186/cc12838 · Cited by 120
Stochastic Targeted (STAR) Glycemic Control: Design, Safety, and Performance
Evans, A., Compte, A. L., Tan, C.-S., Ward, L., Steel, J., Pretty, C. G., Penning, S., Suhaimi, F. M., Shaw, G. M., Desaive, T., et al. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600113 · Cited by 131
Hyperglycemia and Perioperative Glucose Management
E. Duncan, A. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212803832236 · Cited by 119
Safety, efficacy and clinical generalization of the STAR protocol: a retrospective analysis
Stewart, K. W., Pretty, C. G., Tomlinson, H., Thomas, F., Homlok, J., Némedi, N. S., Illyés, A., Shaw, G. M., Benyó, B. I., & Chase, J. G. (2016) · Annals of Intensive Care · doi:10.1186/s13613-016-0125-9 · Cited by 123
Schricker, T., & Lattermann, R. (2015) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-014-0274-y · Cited by 139
The impact of the severity of sepsis on the risk of hypoglycaemia and glycaemic variability
Waeschle, R. M., Moerer, O., Hilgers, R., Herrmann, P., Neumann, P., & Quintel, M. (2008) · Critical Care · doi:10.1186/cc7097 · Cited by 115
Bellido, V., Suarez, L., Rodriguez, M. G., Sanchez, C., Dieguez, M., Riestra, M., Casal, F., Delgado, E., Menendez, E., & Umpierrez, G. E. (2015) · Diabetes Care · doi:10.2337/dc15-0160 · Cited by 118
“glycemic variability during the entire stay (23); and 2) determination of the coefficient of variation of glucose measures, which represents the average daily glycemic excursion (24); and 3) determination of the mean amplitude of glycemic excursions, which is the arithmetic mean of the absolute value of BG level excur…”
BackgroundSubramaniam, B., Lerner, A., Novack, V., Khabbaz, K., Paryente-Wiesmann, M., Hess, P., & Talmor, D. (2014) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000000100 · Cited by 117
Acute insulin resistance following injury
Li, L., & Messina, J. L. (2009) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2009.06.004 · Cited by 114
Intensive Insulin Therapy in Severe Traumatic Brain Injury: A Randomized Trial
Coester, A., Neumann, C. R., & Schmidt, M. I. (2010) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e3181c9afc2 · Cited by 139
Clinical Implications of Glucose Variability: Chronic Complications of Diabetes
Jung, H. S. (2015) · Endocrinology and Metabolism · doi:10.3803/enm.2015.30.2.167 · Cited by 103
Brunner, R., Adelsmayr, G., Herkner, H., Madl, C., & Holzinger, U. (2012) · Critical Care · doi:10.1186/cc11657 · Cited by 112
Krinsley, J. S., Meyfroidt, G., den Berghe, G. V., Egi, M., & Bellomo, R. (2012) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32834f0009 · Cited by 100
Self-citationThe metrics of glycaemic control in critical care
Mackenzie, I. M. J., Whitehouse, T., & Nightingale, P. (2011) · Intensive Care Medicine · doi:10.1007/s00134-010-2103-2 · Cited by 594
Glycaemic control in the perioperative period
Sebranek, J. J., Lugli, A. K., & Coursin, D. B. (2013) · British Journal of Anaesthesia · doi:10.1093/bja/aet381 · Cited by 101
Pilot proof of concept clinical trials of Stochastic Targeted (STAR) glycemic control
Evans, A., Shaw, G. M., Compte, A. L., Tan, C.-S., Ward, L., Steel, J., Pretty, C. G., Pfeifer, L., Penning, S., Suhaimi, F. M., et al. (2011) · Annals of Intensive Care · doi:10.1186/2110-5820-1-38 · Cited by 99
Lanspa, M. J., Dickerson, J., Morris, A. H., Orme, J. F., Holmen, J. R., & Hirshberg, E. L. (2014) · Critical Care · doi:10.1186/cc13851 · Cited by 98
Krinsley, J. S., Rule, P., Pappy, L., Ahmed, A., Huley-Rodrigues, C., Prevedello, D., & Preiser, J. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004599 · Cited by 91
Self-citationPretty, C. G., Compte, A. J. L., Chase, J. G., Shaw, G. M., Preiser, J., Penning, S., & Desaive, T. (2012) · Annals of Intensive Care · doi:10.1186/2110-5820-2-17 · Cited by 99
Hyperglycemia in Critically Ill Patients: Management and Prognosis
Godinjak, A., Iglica, A., Bureković, A., Jusufović, S., Ajanovic, A., Tančica, I., & Kukuljac, A. (2015) · Medical Archives · doi:10.5455/medarh.2015.69.157-160 · Cited by 88
Daviaud, F., Dumas, F., Demars, N., Géri, G., Bouglé, A., Morichau-Beauchant, T., Nguyen, Y.-L., Bougouin, W., Pène, F., Charpentier, J., et al. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3269-9 · Cited by 88
Egi, M., Finfer, S. R., & Bellomo, R. (2011) · CHEST Journal · doi:10.1378/chest.10-1478 · Cited by 95
A Consensus Statement for Continuous Glucose Monitoring Metrics for Inpatient Clinical Trials
Spanakis, E. K., Cook, C. B., Kulasa, K. M., Aloi, J., Bally, L., Davis, G. M., Dungan, K. M., Galindo, R. J., Mendez, C. E., Pasquel, F. J., et al. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231191104 · Cited by 92
Epigenetic modification and therapeutic targets of diabetes mellitus
Singh, R., Chandel, S., Dey, D., Ghosh, A., Roy, S., Ravichandiran, V., & Ghosh, D. (2020) · Bioscience Reports · doi:10.1042/bsr20202160 · Cited by 88
Long-term changes in dysnatremia incidence in the ICU: a shift from hyponatremia to hypernatremia
Lansink‐Hartgring, A. O., Hessels, L., Weigel, J. D., de Smet, A. M. G. A., Gommers, D. A. M. P. J., Panday, P. V. N., Hoorn, E. J., & Nijsten, M. W. (2016) · Annals of Intensive Care · doi:10.1186/s13613-016-0124-x · Cited by 84
El-Laboudi, A. H., Godsland, I. F., Johnston, D. G., & Oliver, N. S. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0146 · Cited by 84
Metabolic and Nutrition Support in the Chronic Critical Illness Syndrome
Schulman, R. C., & Mechanick, J. I. (2012) · Respiratory Care · doi:10.4187/respcare.01620 · Cited by 82
Hessels, L., Hoekstra, M., Mijzen, L. J., Vogelzang, M., Dieperink, W., Lansink‐Hartgring, A. O., & Nijsten, M. W. (2015) · Critical Care · doi:10.1186/s13054-014-0720-9 · Cited by 83
Siegelaar, S. E., Hermanides, J., Oudemans-van Straaten, H. M., van der Voort, P. H., Bosman, R. J., Zandstra, D. F., & DeVries, J. H. (2010) · Critical Care · doi:10.1186/cc9369 · Cited by 82
Society for Maternal-Fetal Medicine Consult Series #67: Maternal sepsis
Shields, A. D., Plante, L. A., Pacheco, L. D., & Louis, J. M. (2023) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2023.05.019 · Cited by 92
A Diabetes-Specific Enteral Formula Improves Glycemic Variability in Patients with Type 2 Diabetes
Alish, C. J., Garvey, W. T., Maki, K. C., Sacks, G. S., Hustead, D. S., Hegazi, R. A., & Mustad, V. A. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0185 · Cited by 77
Wang, A., Liu, X., Xu, J., Han, X., Su, Z., Chen, S., Zhang, N., Wu, S., Wang, Y., & Wang, Y. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006757 · Cited by 78
Li, J., Huang, M., & Shen, X. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.06.008 · Cited by 79
Dysglycaemia in the critically ill – significance and management
Deane, A. M., & Horowitz, M. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12078 · Cited by 81
Association between HbA1c variability and mortality in patients with type 2 diabetes
Takao, T., Matsuyama, Y., Yanagisawa, H., Kikuchi, M., & Kawazu, S. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.02.006 · Cited by 78
Glucose homeostasis, nutrition and infections during critical illness
Ingels, C., Vanhorebeek, I., & den Berghe, G. V. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.12.033 · Cited by 78
Kurtz, P., Claassen, J., Helbok, R., Schmidt, J. M., Fernández-Salazar, L. I., Presciutti, M., Stuart, R. M., Connolly, E. S., Lee, K., Badjatia, N., et al. (2014) · Critical Care · doi:10.1186/cc13857 · Cited by 81
Ballesteros, M. Á., Hernández-Tejedor, A., Estella, Á., Rivera, J. J. J., de Molina, F. J. G., Camps, A. S., Vidal, P., de Haro, C., Aguilar-Alonso, E., Laguna, L. B., et al. (2020) · Medicina Intensiva · doi:10.1016/j.medin.2020.04.001 · Cited by 81
Munoz, M., Pronovost, P., Dintzis, J., Kemmerer, T., Wang, N.-Y., Chang, Y.-T., Efird, L., Berenholtz, S. M., & Golden, S. H. (2012) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/s1553-7250(12)38025-2 · Cited by 73
The Assessment of Glycemic Variability and Its Impact on Diabetes-Related Complications: An Overview
Weber, C., & Schnell, O. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0043 · Cited by 72
Schierenbeck, F., Franco-Cereceda, A., & Liska, J. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816651632 · Cited by 71
Lanspa, M. J., Krinsley, J. S., Hersh, A. M., Wilson, E. L., Holmen, J. R., Orme, J. F., Morris, A. H., & Hirshberg, E. L. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.05.016 · Cited by 73
Self-citationNaidech, A. M., Levasseur‐Franklin, K. E., Liebling, S. M., Garg, R. K., Shapiro, M., Ault, M. L., Afifi, S., & Batjer, H. H. (2009) · Neurocritical Care · doi:10.1007/s12028-009-9311-z · Cited by 72
Untangling glycaemia and mortality in critical care
Uyttendaele, V., Dickson, J. L., Shaw, G. M., Desaive, T., & Chase, J. G. (2017) · Critical Care · doi:10.1186/s13054-017-1725-y · Cited by 75
Expert consensus on the glycemic management of critically ill patients
Wu, Z., Liu, J., Zhang, D., Kang, K., Zuo, X., Xu, Q., Pan, A., Fang, W., Liu, F., Shang, Y., et al. (2022) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2022.06.001 · Cited by 73
Signal, M., Le Compte, A., Shaw, G. M., & Chase, J. G. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600506 · Cited by 68
High Glucose Variability Increases Mortality Risk in Hospitalized Patients
Akirov, A., Diker-Cohen, T., Masri-Iraqi, H., & Shimon, I. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00450 · Cited by 68
Lanspa, M. J., Hirshberg, E. L., Phillips, G. D., Holmen, J. R., Stoddard, G. J., & Orme, J. F. (2012) · CHEST Journal · doi:10.1378/chest.12-2072 · Cited by 73
Meynaar, I. A., Eslami, S., Abu–Hanna, A., der Voort, P. V., de Lange, D. W., & de Keizer, N. F. (2012) · Journal of Critical Care · doi:10.1016/j.jcrc.2011.11.004 · Cited by 77
Suhaimi, F. M., Compte, A. L., Preiser, J., Shaw, G. M., Massion, P. B., Radermecker, R. P., Pretty, C. G., Lin, J., Desaive, T., & Chase, J. G. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400208 · Cited by 68
Krinsley, J. S., Preiser, J., & Hirsch, I. B. (2016) · Endocrine Practice · doi:10.4158/ep161532.or · Cited by 66
Self-citationAdvances in Medical Nutrition Therapy: Parenteral Nutrition
Itzhaki, M. H., & Singer, P. (2020) · Nutrients · doi:10.3390/nu12030717 · Cited by 73
Management of hyperglycemia in hospitalized patients
Smiley, D., & Umpierrez, G. E. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05805.x · Cited by 64
Metadata
- Authors
- Krinsley, J. S.
- Affiliations
- Stamford Hospital (US)
- Corresponding author
- Krinsley, James S.
- ORCID
- Krinsley, James S.
- Venue
- Critical Care Medicine
- Published
- 2008-11
- Volume
- 36
- Issue
- 11
- Pages
- 3008-3013
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2075443305
- Semantic Scholar
- 79cd4ec5e405e5c3178f4ac71f13f47adf512e7a
- Cited by
- 729
- References
- 27
- Citations by year
- 2026: 23 · 2025: 15 · 2024: 15 · 2023: 24 · 2022: 29 · 2021: 39 · 2020: 41 · 2019: 41 · 2018: 36 · 2017: 42 · 2016: 43 · 2015: 44 · 2014: 58 · 2013: 50 · 2012: 72
- FWCI
- 37.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
- Keywords
- glycemic variability, mortality, critically ill patients, intensive care unit, glycemic control, normoglycemia, APACHE II score, length of hospital stay, risk factors
- MeSH terms
- Aged, Blood Glucose, Critical Care, Humans, Hypoglycemia, Length of Stay, Prospective Studies, Retrospective Studies, Critical Illness, APACHE
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.